Silencing of BCL11A expression in erythroid progenitors leads to increased HbF production, which ameliorates the clinical phenotype of SCD and β-thalassemia by reducing hemoglobin polymerization and ineffective erythropoiesis. The gene discussed is BCL11A; the disease is Schnyder corneal dystrophy.